Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $625.0000 (3.31%) ($600.0000 - $625.0000) on Fri. Feb. 12, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.5% (three month average) | RSI | 54 | Latest Price | $625.0000(3.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.75% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.75% (StdDev 5.5%) | Hourly BBV | 0 () | Intraday Trend | 4.2% | | | |
|
5 Day Moving Average | $596.25(4.82%) | 10 Day Moving Average | $596.45(4.79%) | 20 Day Moving Average | $586.69(6.53%) | To recent high | -21.9% | To recent low | 17.9% | Market Cap | $12.311b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |